Barbara Ikejiri

1.2k total citations
28 papers, 901 citations indexed

About

Barbara Ikejiri is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Barbara Ikejiri has authored 28 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Immunology and 8 papers in Oncology. Recurrent topics in Barbara Ikejiri's work include Immune Cell Function and Interaction (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Immunotherapy and Immune Responses (5 papers). Barbara Ikejiri is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Immunotherapy and Immune Responses (5 papers). Barbara Ikejiri collaborates with scholars based in United States, United Kingdom and Malaysia. Barbara Ikejiri's co-authors include Edward H. Oldfield, Zhengping Zhuang, Eli Kedar, Abha Saxena, J T Robertson, Russell R. Lonser, Alexander O. Vortmeyer, Ronald B. Herberman, Chunzhang Yang and W. Craig Clark and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Barbara Ikejiri

28 papers receiving 874 citations

Peers

Barbara Ikejiri
Sasidhar Vemula United States
Ann M. Pace United States
Ren Xu United States
H. J. Altermatt Switzerland
Barbara Ikejiri
Citations per year, relative to Barbara Ikejiri Barbara Ikejiri (= 1×) peers Jerzy Trojan

Countries citing papers authored by Barbara Ikejiri

Since Specialization
Citations

This map shows the geographic impact of Barbara Ikejiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Ikejiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Ikejiri more than expected).

Fields of papers citing papers by Barbara Ikejiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Ikejiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Ikejiri. The network helps show where Barbara Ikejiri may publish in the future.

Co-authorship network of co-authors of Barbara Ikejiri

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Ikejiri. A scholar is included among the top collaborators of Barbara Ikejiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Ikejiri. Barbara Ikejiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Chunzhang, Herui Wang, Dongwang Zhu, et al.. (2015). Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation. Proceedings of the National Academy of Sciences. 112(4). 1137–1142. 21 indexed citations
2.
Yang, Chunzhang, Albert Cheung-Hoi Yu, Raymund L. Yong, et al.. (2012). β-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomas. Proceedings of the National Academy of Sciences. 109(18). 6963–6968. 69 indexed citations
3.
Lu, Jie, Zhengping Zhuang, Debbie K. Song, et al.. (2009). The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma. Journal of neurosurgery. 113(2). 225–233. 27 indexed citations
4.
Li, Jie, Chunyue Yin, Hiroaki Okamoto, et al.. (2008). Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas. Neuro-Oncology. 10(1). 45–51. 33 indexed citations
5.
Tran, Maxine, Wei Zeng, Sven Gläsker, et al.. (2006). Evolution of VHL tumourigenesis in nerve root tissue. The Journal of Pathology. 210(3). 374–382. 35 indexed citations
6.
Lubensky, Irina A., Alexander O. Vortmeyer, Stephanie Kim, et al.. (2006). Identification of Tumor Precursor Cells in the Brains of Primates with Radiation-Induced de novo Glioblastoma Multiforme. Cell Cycle. 5(4). 452–456. 11 indexed citations
7.
Gläsker, Sven, et al.. (2006). Epididymal cystadenomas and epithelial tumourlets: effects of VHL deficiency on the human epididymis. The Journal of Pathology. 210(1). 32–41. 30 indexed citations
8.
Vogel, Timothy W., Alexander O. Vortmeyer, Irina A. Lubensky, et al.. (2005). Coexpression of erythropoietin and its receptor in endolymphatic sac tumors. Journal of neurosurgery. 103(2). 284–288. 7 indexed citations
9.
Lee, Youn‐Soo, Alexander O. Vortmeyer, Irina A. Lubensky, et al.. (2005). Coexpression of Erythropoietin and Erythropoietin Receptor in Von Hippel-Lindau Disease–Associated Renal Cysts and Renal Cell Carcinoma. Clinical Cancer Research. 11(3). 1059–1064. 50 indexed citations
10.
Vortmeyer, Alexander O., Stephan Frank, Kristy C. Yuan, et al.. (2003). Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease.. PubMed. 63(21). 7051–5. 80 indexed citations
11.
Proescholdt, Martin, Marsha J. Merrill, Barbara Ikejiri, et al.. (2001). Site-specific immune response to implanted gliomas. Journal of neurosurgery. 95(6). 1012–1019. 25 indexed citations
12.
Robertson, J T, et al.. (1994). ALLELIC DELETIONS ON CHROMOSOME-17 AND MUTATIONS IN THE P53 GENE IN TUMORS METASTATIC TO BRAIN. International Journal of Oncology. 4(1). 37–42. 2 indexed citations
13.
Plunkett, Robert J., Stephen C. Saris, Krzysztof S. Bankiewicz, Barbara Ikejiri, & Richárd Wéber. (1989). Implantation of dispersed cells into primate brain. Journal of neurosurgery. 70(3). 441–445. 7 indexed citations
14.
Barba, David, et al.. (1988). Morphology of Interleukin-2-Stimulated Human Peripheral Blood Mononuclear Effector Cells Killing Glioma-Derived Tumor Cells In Vitro. JNCI Journal of the National Cancer Institute. 80(3). 171–177. 19 indexed citations
15.
Ikejiri, Barbara, et al.. (1987). Opiate receptor mediated regulation of the immune response in vivo.. PubMed. 76. 341–8. 33 indexed citations
16.
Lanza, Lorella, et al.. (1986). Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.. The Journal of Immunology. 137(8). 2716–2720. 15 indexed citations
17.
Kedar, Eli, Barbara Ikejiri, Tuomo Timonen, et al.. (1983). Antitumor reactivity in vitro and in vivo of lymphocytes from normal donors and cancer patients propagated in culture with T cell growth factor (TCGF). European Journal of Cancer and Clinical Oncology. 19(6). 757–773. 11 indexed citations
18.
Kedar, Eli, Barbara Ikejiri, Guy D. Bonnard, & Ronald B. Herberman. (1982). A rapid technique for isolation of viable tumor cells from solid tumors: Use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses. European Journal of Cancer and Clinical Oncology. 18(10). 991–1000. 50 indexed citations
19.
Kedar, Eli, Barbara Ikejiri, Benjamin Sredni, Benjamin Bonavida, & Ronald B. Herberman. (1982). Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cells. Cellular Immunology. 69(2). 305–329. 30 indexed citations
20.
Bonavida, Benjamin, Barbara Ikejiri, & Eli Kedar. (1976). Direct estimation of frequency of cytotoxic T lymphocytes by a modified plaque assay. Nature. 263(5580). 769–771. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026